3. As of noon trading, Novartis ( NVS) is down $0.46 (-0.6%) to $81.32 on light volume. Thus far, 398,158 shares of Novartis exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $81.31-$81.64 after having opened the day at $81.58 as compared to the previous trading day's close of $81.78. Novartis AG engages in the research, development, manufacture, and marketing of a range of healthcare products worldwide. Novartis has a market cap of $196.8 billion and is part of the drugs industry. The company has a P/E ratio of 20.8, above the S&P 500 P/E ratio of 17.7. Shares are up 1.7% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts that rate Novartis a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates Novartis as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Novartis Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.